Hematology TimesEmicizumab granted priority review for hemophilia A without inhibitorsJune 7, 2018ThrombosisPharmacyBleeding Disorders
Hematology NewsEmicizumab gets priority review for hemophilia A without inhibitorsJune 5, 2018Bleeding Disorders
Hematology TimesPerioperative rVWF alone sufficient for some VWD patientsMay 24, 2018ThrombosisBleeding Disorders
Hematology TimesEmicizumab controls bleeding regardless of inhibitorsMay 24, 2018ThrombosisBleeding Disorders
Hematology TimesGene therapy reduces ABR, AIR in hemophilia BMay 23, 2018ThrombosisBleeding Disorders
Hematology TimesN9-GP has better PK profile than rFIXFc, team saysMay 23, 2018ThrombosisBleeding Disorders
Hematology NewsFDA approves Doptelet for liver disease patients undergoing proceduresMay 22, 2018Bleeding DisordersGastroenterologyGastrointestinal Cancer
Hematology NewsStructured PPH management cuts severe hemorrhageMay 11, 2018Bleeding DisordersBusiness of Medicine
Hematology NewsNHLBI seeks to accelerate hemostasis/thrombosis researchMay 3, 2018Bleeding DisordersThrombosis
